Protalix BioTherapeutics, Inc. (PLX) stock is tumbling today: Why is it so?

AEYE Stock

Shares of the Protalix BioTherapeutics, Inc. (PLX)  stock were tumbling today following the release of the updated data related to the clinical development of PRX-102 for the treatment of patients suffering from Fabry Disease. PLX stock price saw a downtrend of  14.77% to drop at $2.54 a share as of this writing. At the previous […]

H.C. Wainwright reiterates Protalix BioTherapeutics Inc. [PLX] at Buy and assigns price target at $11

ASTR Stock

H.C. Wainwright maintained its Protalix BioTherapeutics Inc. [AMEX:PLX]‎ rating to the equivalent of ‎Buy but changed the price target ‎to $11, in a research note dated December 31, 2020. That figure ‎represents around a 212.5% ‎premium ‎from where the company’s shares closed on Wednesday.‎ Other ‎analysts also ‎revised their coverage, with H.C. Wainwright’s analysts reiterating […]